CCL2 and diabetes mellitus: Analogous findings were noted in the case of plasma C-C motif chemokine ligand 2 (CCL2)/JE monocyte chemoattractant peptide-1 (JE/MCP1), which was upregulated in diabetes and at 150 or 50 ppm/day, in both male and female mice, significantly lower CCL2 was noted vs. vehicle treatment [87].